Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07020273 · ClinicalTrials.gov registry record · NA
CONNECT Cancer Survivors With Tobacco Treatment
A NA study of Smoking Cessation and Tobacco Use, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 5,000
- Enrollment target
- 1
- Study location
NCT07020273: Recruiting NA study of Smoking Cessation and Tobacco Use, sponsored by Washington University School of Medicine.
NCT07020273 is a NA study of Smoking Cessation and Tobacco Use that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 5,000 participants, above the 448-participant average among 188 other Smoking Cessation trials with a reported enrollment target (1016% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07020273, a NA study of Smoking Cessation and Tobacco Use, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the comparative effectiveness of two different informatics-enabled implementation strategies on increasing tobacco treatment and improving smoking cessation rates for cancer control and prevention. This will be done via a two-arm pragmatic cluster randomized trial (CRT) to test the effectiveness of nudges to change (ELEVATE-S) vs. quit-focused usual care (ELEVATE) in increasing tobacco treatment (use of medication, brief advice, or referral to external counseling) and smoking cessation.
Primary Outcome
This will be quantified by the proportion of enrolled patients who receive tobacco use treatment (either medication or behavioral intervention (brief advice or referral to counseling)).
Conditions Studied
Interventions
- BEHAVIORAL ELEVATE
- BEHAVIORAL ELEVATE-S
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2025-07-01 |
| Est. Completion | 2027-01-01 |
| Phase | NA |
What NCT07020273 shows while recruiting
NCT07020273 is an interventional study that assigns participants to a tested intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 448-participant average among 188 other Smoking Cessation trials with a reported enrollment target (1016% higher).
The record links to 5 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which ELEVATE is the first listed.
NCT07020273 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT07020273 about?
NCT07020273 is a clinical study titled "CONNECT Cancer Survivors With Tobacco Treatment". The purpose of this study is to evaluate the comparative effectiveness of two different informatics-enabled implementation strategies on increasing tobacco treatment and improving smoking cessation rates for cancer control and prevention. This will be done via a two-arm pragmatic cluster randomized ...
What is the current status of trial NCT07020273?
This trial is currently recruiting. It is a NA study. The enrollment target is 5,000 participants. The study started on 2025-07-01. Estimated completion is 2027-01-01.
What conditions does trial NCT07020273 study?
This clinical trial studies the following conditions: Smoking Cessation, Tobacco Use, Tobacco Smoking, Tobacco Use Cessation, Nicotine Addiction.
What interventions are being tested in trial NCT07020273?
The interventions under investigation include: ELEVATE (BEHAVIORAL), ELEVATE-S (BEHAVIORAL).
Who is sponsoring clinical trial NCT07020273?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07020273 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07020273's enrollment target sits among peer trials
5,000 2nd of 188 the highest of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI